Compugen Limited (CGEN) Sof foyda bo'yicha sotuv rentabelligi

Compugen Ltd (CGEN) tovar belgisi

Compugen Ltd. ishlab chiqarish va sinovlarni to'liq autsorsing qilish orqali kapital xarajatlarini minimallashtiradi. GURU.Markets terminali sof savdo marjasi grafigini namoyish etadi, bunda 47.90 darajasi joriy qiymatni ifodalaydi. Antitanalarni ishlab chiqishni tezlashtirish uchun sog'liqni saqlash gigantlari bilan tuzilgan strategik ittifoqlar boshqaruv samaradorligini oshiradi, tadqiqot va ishlanmalar (R&D) yadrosining barqarorligi esa yetakchi immunologlarning yuqori sodiqligi bilan ta'minlanadi.

CGEN: cgen.com Kompaniyaning sof rentabelligi 04.07.2022 - 19.11.2026

Compugen Ltd. kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:Compugen Limited - CGEN
cgen.com yetakchi tovari

Sotuv marjasi har bir dollar daromadning sof foydaga nisbatini o'lchaydi, bu esa xarajatlarni boshqarish samaradorligini va operatsion faoliyatning haqiqiy daromadliligini ochib beradi. Sof marjinal sotuvlar daromadining tahlili Compugen Ltd. (CGEN) kompaniyasi kompyuterli dori vositalarini kashf qilish va saraton immunoterapiyasi sohasidagi ishlanmalarini qanchalik muvaffaqiyatli monetizatsiya qilayotganini baholash imkonini beradi hamda ushbu yuqori texnologik biznesning moliyaviy barqarorligini tasdiqlaydi.

Raqobatchilar tahlili

NantKwest (IBRX) - Sof marja|Sof marja Immunocore PLC (IMCR)|Sof foyda bo'yicha sotuv rentabelligi JANX|RCUS - Sof foyda bo'yicha marjinallik|Sof foyda bo'yicha sotuv rentabelligi ZYME (Zymeworks Corp)|Kompaniyaning sof rentabelligi TNGX|Sotuvning sof marjinal rentabelligi IOVA (Iovance Biotherapeutics, Inc.)|Sof foyda normasi IMTX|xencor.com - Sotuvning sof marjinal rentabelligi|Sof marja Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Sof marja|Lyell Immunopharma - Sof foyda normasi|IPHA (innate-pharma.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi pyxisoncology.com|Sof marja IO Biotech (IOBT)|STRO: Sof foyda marjasi|MiNK Therapeutics Inc. - Sof foyda bo'yicha sotuv rentabelligi|werewolftx.com (HOWL) - Sof marja|Immix Biopharma Inc. - Sotuvning sof marjinal rentabelligi|ALXO - Sotuvning sof marjinal rentabelligi|CUE: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi PDSB|Sof marja Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi LIMN|Sotuvning sof marjinal rentabelligi Lava Tx (LVTX)|Sotuvning sof marjinal rentabelligi NXTC (NextCure Corporation)|Sof foyda normasi LPTX|INTS - Sof marja|Kompaniya sotuv marjasi Sensei Biotherapeutics Inc SNSE|TOVX: Sotuvning sof marjinal rentabelligi|Sof marja Gritstone Bio (GRTS)|KA (Kineta Corp) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi NEXI (NexImmune Corp)|Sotuvning sof marjinal rentabelligi TSBX|VCNX (Vaccinex, Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi HARP (Harpoon Therapeutics, Inc.)